Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-06 |
mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0009 |
mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.004 |
mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |